The Medical Supply Market in 2026

Most people who search for a "medical supply business plan" are not planning to open a clinic. They're planning to sell or distribute the physical products a clinic, home carer or patient needs - wheelchairs, hospital beds, oxygen concentrators, CPAP machines, wound care dressings, incontinence supplies, mobility aids. That distinction matters, because the regulatory path, the funding model and the margin structure for a medical supply retailer or durable medical equipment (DME) supplier are completely different from a healthcare provider's, and most generic templates blur the two.

The global medical supplies market was valued at $151.86 billion in 2025 and is forecast to reach $223.22 billion by 2035, a 3.39% compound annual growth rate from 2026 onward, with North America holding the largest regional share at 36%. Precedence Research, 2026

The UK medical devices market - the closest published category to "medical supply" - was valued at approximately $19.07 billion in 2025, projected to reach $27.90 billion by 2032 at a 5.6% CAGR. Fortune Business Insights, 2026 Within that, the narrower disabled and elderly assistive device segment - the mobility aids, riser-recliners and home adaptations that make up most of a UK medical supply storefront's stock - was worth $1.16 billion in 2023 and is growing at 12.4% annually toward $2.81 billion by 2030, among the fastest-growing sub-segments in UK healthcare retail. Next Move Strategy Consulting, 2026

The distribution side of this industry is more fragmented than most founders expect. The five largest players - Cardinal Health, McKesson, Medline, Owens & Minor and Henry Schein - control roughly 20% of total market revenue between them, which means 80% of the market is served by regional and independent distributors and retailers. GMI Insights, 2026 That fragmentation is the opportunity: a well-run local or regional medical supply business competes on delivery speed, payer-relationship management and product curation, not on trying to out-scale national distributors.

Demand is structurally durable rather than cyclical. Aging populations in the US and UK, the shift of post-acute recovery from hospitals to home settings, and rising chronic-disease prevalence all push more equipment and consumable spend into the home - which is exactly the channel an independent medical supply business serves.

Who Actually Buys From a Medical Supply Business

A medical supply business plan needs to name its buyer segments precisely, because each one has a different sales cycle and a different margin profile. Three groups drive most of the revenue:

• Discharge-planned patients and family caregivers - referred by a hospital discharge planner, home health agency or GP surgery after a surgery, fall or new diagnosis; typically the highest-margin, most loyal segment because the relationship starts with a specific, urgent need and often converts into a recurring resupply account
• Self-directed cash-pay customers - people buying mobility aids, bathroom safety equipment or wellness products directly, usually online or walk-in, with no insurance billing involved; fastest to close, highest gross margin, but the smallest average order value
• Institutional and contract buyers - care homes, assisted-living facilities, physiotherapy clinics and small home health agencies buying on account or via standing order; lower margin per unit but high order frequency and strong revenue predictability once the contract is signed

The businesses that scale fastest in this niche are the ones that treat the discharge-planner and home-health-agency relationship as a sales channel in its own right - building a referral pipeline the same way a B2B business builds a partner network - rather than waiting for cash-pay walk-in traffic alone.

Demand also carries a mild seasonal pattern worth building into a 12-month cash flow forecast: cash-pay mobility and bathroom-safety sales rise in January (New Year health resolutions and post-holiday fall injuries among older relatives visiting family) and again in September as colder weather increases fall risk and respiratory equipment demand. Institutional and discharge-referral revenue is comparatively flat year-round, which is another reason a healthy business plan blends both segments rather than leaning on cash-pay retail alone.

Financing Routes & SBA Loan Data

Medical supply and DME businesses sit across two relevant NAICS codes: 446199 (All Other Health and Personal Care Stores, the retail classification that covers medical equipment and supplies stores) and 423450 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers, the wholesale/distribution classification). The SBA's small-business size standard for 423450 is 200 employees or fewer, which covers essentially every independent operator in this space. NAICS.com, 2026

SBA 7(a) loans remain the primary financing route for both retail and wholesale medical supply startups in the US, offering up to $5 million with terms up to 25 years for real estate and up to 10 years for working capital and inventory. U.S. Small Business Administration, 2026 Because inventory-heavy retail categories carry a national SBA-approved average loan size around $340,000 - with general merchandise and specialty retail categories often landing 40-55% below that national average - most first-time medical supply founders should model a realistic ask in the $100,000-$250,000 range rather than anchoring to the national mean.

A financing detail that catches almost every new applicant off guard: an SBA loan or bank line of credit will not cover your DMEPOS accreditation survey fee or your $50,000 Medicare surety bond premium as "inventory" or "equipment" - lenders want those itemised separately as a compliance/working-capital line, because they represent a recurring three-year cost rather than a one-time capital purchase. Structuring your ask this way, rather than folding accreditation costs into a generic "startup costs" bucket, is one of the fastest ways to get a lender to take a first-time DME applicant seriously.

In the UK, the Start Up Loans scheme offers up to £25,000 per founder (up to £100,000 for a multi-founder team) at 6% fixed interest with free mentoring, and is commonly stacked with a Growth Guarantee Scheme-backed bank loan or private investment for the inventory-heavy portion of the raise. Equipment leasing - financing mobility aids, hospital beds and respiratory equipment through a lease-to-own arrangement rather than an outright purchase - is also standard practice on both sides of the Atlantic, since it preserves cash for accreditation and working capital in the accreditation-to-first-reimbursement gap.

Beyond bank and SBA debt, two alternative routes are worth naming in a funding-ask section. Vendor financing - a distributor extending 30-60 day payment terms on an initial inventory order - effectively functions as free short-term working capital and is common once a founder has an established relationship with a wholesaler like Cardinal Health or Medline. Equipment manufacturers also periodically run dealer-incentive programmes that discount or defer payment on starter inventory for newly accredited suppliers, which is worth asking about directly rather than assuming list price is the only option.

Startup Capital & Cost Breakdown

Opening a medical supply business typically requires $85,000 to $490,000 (£67,000 to £387,000) in initial capital. The wide range reflects three genuinely different business models sitting under one search term: a small cash-pay/online reseller can launch for as little as $5,000-$10,000, a single-location DME storefront with Medicare billing needs $80,000-$200,000, and a multi-category retail-plus-wholesale operation with a delivery fleet can run past $450,000.

Cost Breakdown

• Initial inventory: $30K–$150K (£24K–£119K) - mobility aids, respiratory equipment, wound care, incontinence supplies, general DME
• Storefront or warehouse lease & fit-out (1,000–3,000 sq ft): $25K–$180K (£20K–£142K)
• DMEPOS accreditation prep, survey fees & $50,000 surety bond premium: $5K–$15K (£4K–£12K)
• Staffing - delivery drivers, billing specialist, resupply coordinator: $10K–$65K (£8K–£51K)
• DME billing/inventory software and delivery vehicle: $10K–$55K (£8K–£43K)
• Liability, product and cargo/delivery insurance: $3K–$14K (£2K–£11K)
• Marketing and referral-network development (discharge planners, home health agencies, GP surgeries): $5K–$22K (£4K–£17K)

Funding Routes

In the US, SBA 7(a) loans, equipment leasing (particularly for hospital beds, oxygen concentrators and mobility equipment), and vendor financing from distributors are the three most common capital sources. Many founders combine a modest SBA loan with a lease-to-own equipment arrangement to avoid tying up working capital in depreciating stock before Medicare reimbursements start flowing.

In the UK, the Start Up Loans scheme (up to £25,000 at 6% fixed) is typically paired with the Growth Guarantee Scheme or a private investor for the larger inventory and premises portion of the raise. Equipment leasing through medical equipment finance specialists is standard for mobility and respiratory stock.

Suppliers & Distribution Partners

Almost no independent medical supply business manufactures its own stock. Margin and reliability come from who you buy through, not what you make - so the supplier relationships section of your business plan carries real weight with lenders and investors. The wholesale layer of this industry is dominated by five names, and most independents buy through one or more of them rather than negotiating directly with manufacturers:

• Cardinal Health - founded 1971, dual-headquartered in Dublin, Ireland and Columbus, Ohio; supplies more than 75% of U.S. hospitals and is a common primary distributor for independent DME retailers
• McKesson Corporation - one of the oldest medical distributors in the US, tracing back to 1833, headquartered in Irving, Texas; distributes over 300,000 products
• Medline Industries - $28.4 billion in net sales for FY2025; operates 69 global distribution centers and 26 North American manufacturing sites with next-day delivery to 95% of US customers
• Owens & Minor - a major medical-surgical distributor that expanded into DME by acquiring Rotech Healthcare, signalling how consolidated the wholesale-to-retail pipeline is becoming
• Henry Schein - $13.2 billion in 2025 sales, operating in 34 countries with a catalog of over 300,000 branded and private-label products

For equipment-specific manufacturers rather than general wholesalers, independent retailers most commonly stock Invacare, Drive DeVilbiss Healthcare and Compass Health Brands for wheelchairs, hospital beds and mobility aids, alongside newer direct-to-retail brands like Vive Health for private-pay accessory lines.

On the retail and DME-accredited competitor side - useful benchmarking for a competitive-landscape section - the largest national and regional operators include Aeroflow Health (insurance-focused DME with a strong digital ordering funnel), Rotech Healthcare and Lincare (both respiratory-equipment specialists), Byram Healthcare and CCS Medical (diabetes and chronic-condition supply specialists). None of them compete primarily on price - they compete on reimbursement-cycle speed and resupply automation, which is where a new entrant's operational plan should focus too.

On the software side, most new operators choose between Brightree, the long-standing HME/DME platform used by larger multi-location operators for its depth of billing and analytics, and NikoHealth, a newer cloud-based alternative built specifically to combine billing, inventory, resupply automation and delivery scheduling in one system for single-location and small multi-location businesses. Either is a reasonable line item to name explicitly in a lender-facing business plan - it signals the founder understands the operational stack, not just the product category.

Outside the US, the supplier landscape looks different but the fragmentation pattern holds. In the UK, independent mobility and home healthcare retailers typically buy through regional wholesalers and direct-to-retail manufacturer accounts rather than the equivalent of a Cardinal Health-scale national distributor, since UK healthcare procurement is more NHS-trust-driven at the institutional level and more fragmented at the private retail level. In Canada, MDEL-licensed distributors and importers serve a similarly regional market, with national pharmacy chains and independent home healthcare stores sourcing through overlapping but smaller wholesale networks. A business plan targeting a non-US market should name the equivalent regional distributors rather than defaulting to the US names above, since a lender or investor reviewing a UK or Canadian plan will expect market-appropriate sourcing detail.

Operations, Fulfillment & Go-To-Market

Two operational systems determine whether a medical supply business is profitable in year two: how orders move from shelf to customer, and how the referral pipeline gets filled without relying on paid advertising alone.

Fulfillment Workflow

• Intake: order arrives via referral, phone, walk-in or online - captured directly into the DME/billing platform (Brightree or NikoHealth) rather than a separate spreadsheet, so insurance eligibility can be checked before the item leaves the shelf
• Verification: for insurance-billed items, eligibility and prior-authorization status are confirmed before dispatch - skipping this step is the single most common cause of denied claims in a new operator's first six months
• Delivery: in-house delivery (a single van covers most single-location operators in year one) or a local courier partnership for lower-value items; delivery SLAs of 24-72 hours are standard for urgent discharge-related orders
• Resupply automation: recurring categories (CPAP supplies, ostomy, wound care, diabetic testing) are set to auto-generate reorders on a payer-approved schedule, which is where most of the year-two revenue growth actually comes from

Go-To-Market Channels

Paid search and social advertising play a smaller role in this industry than in most retail categories, because the highest-value customer segment - discharge-planned patients - is referred, not searched for. A realistic channel mix for a new medical supply business looks like this:

• Referral partnerships: hospital discharge planners, home health agencies, physiotherapy clinics and GP surgeries; this channel typically takes 60-90 days to build but converts at the highest rate and lowest acquisition cost of any channel available
• Local SEO and Google Business Profile: high-intent, low-volume search traffic from people searching for a specific product category ("wheelchair rental near me", "hospital bed for home use") - a smaller channel by volume, but decisive for cash-pay customers who are actively comparing options
• Institutional account development: direct outreach to care homes and assisted-living facilities for standing-order contracts, which stabilise revenue and improve inventory forecasting once two or three accounts are secured
• Retention and resupply marketing: automated reminders and reorder prompts for existing customers on recurring categories - the lowest-cost channel of all, since it's selling to an existing, already-verified customer

A business plan that models a discharge-planner referral pipeline separately from a cash-pay marketing budget will be far more convincing to a lender than one that lumps "marketing" into a single line item, because the two channels have entirely different costs, timelines and conversion assumptions.

How Medical Supply Businesses Make Money

Revenue in this industry comes from three payer types, and the mix matters more than the top-line number. A profitable retail HME (home medical equipment) business typically earns 30-45% of revenue from Medicare/Medicaid reimbursement, 25-50% from cash-pay retail sales, and 20-35% from private/third-party insurance. Each of these has a completely different collection timeline - cash is instant, private insurance settles in weeks, Medicare/Medicaid can take 30-60 days - and a business plan that doesn't model this separately will understate working-capital needs.

Gross margin also varies by channel. Retail HME sales (items sold cash-pay, over the counter or online, with no insurance billing involved) average around 45% gross margin. DME sales billed through insurance run 23-35% gross margin depending on product mix, because Medicare and Medicaid reimbursement rates are set by a fixed fee schedule rather than negotiated - in competitive bidding areas, those fee-schedule rates have been compressed further over the past decade. HomeCare Magazine

Net margin for well-run operators typically lands between 8% and 15%, with the more efficient, better-systemised businesses reaching 15% or higher. The gap between an 8% operator and a 15% operator almost never comes down to pricing power - payer fee schedules cap what you can charge on the insurance-billed side. It comes down to denial-rate management, collections speed, and resupply automation that keeps recurring-revenue customers (CPAP supplies, diabetic testing supplies, wound care) reordering on schedule without manual follow-up.

Worked example: a 2,200 sq ft DME storefront with a payer mix of 40% Medicare/Medicaid, 35% cash and 25% private insurance, generating $1.4 million in annual product sales at a 30% blended gross margin, produces roughly $420,000 in gross profit. After delivery staff, billing overhead, rent, software and the ongoing accreditation/compliance cost base, net margin typically lands in the 10-12% range - consistent with sector benchmarks, and enough to service a $100,000-$250,000 SBA loan comfortably within a 5-7 year term.

Recurring-revenue categories - CPAP resupply, ostomy and wound care consumables, diabetic testing supplies, incontinence products - deserve particular attention in a business plan's revenue model, because they convert a single equipment sale into a recurring monthly order and are the single biggest lever for improving cash-flow predictability in year two and beyond.

DMEPOS Accreditation & Licensing

This is the section where most generic business plan templates fail medical supply founders completely. Licensing here is not a single state business registration - it is a federal accreditation process specific to durable medical equipment, and getting the sequencing wrong is the most common reason new operators run out of cash before their first Medicare payment lands.

Choosing an accreditation organization is itself a strategic decision, not a formality. ACHC is the default choice for most general DME and HME suppliers, with well-documented standards and a large surveyor pool. CHAP makes more sense for a home health agency adding DMEPOS to an existing service line, since its standards are built around a home-based care framework rather than a retail one. Naming your intended accreditation organization in the business plan - rather than a generic "we will obtain the required licenses" line - is a small detail that materially improves how a lender reads the compliance section.

United States

• DMEPOS Medicare Supplier Accreditation - required before you can bill Medicare or Medicaid for durable medical equipment, prosthetics, orthotics or supplies. As of 2026, nine organizations hold CMS approval to accredit DMEPOS suppliers: ACHC, The Compliance Team, the Board of Certification/Accreditation, ABC, CHAP, The Joint Commission, HQAA, NABP and DNV Healthcare. CMS, 2026
• $50,000 Medicare surety bond - required per NPI before enrollment finalizes; the bond's annual premium typically runs $500-$1,500 depending on the applicant's credit profile, not the full $50,000 face value
• CMS "operational location" requirement - your business must have a qualified physical practice location, open to the public, properly staffed and stocked; a personal residence does not qualify
• State DME/pharmacy licensing - varies by state, typically filed per physical location before opening; check your state's Board of Pharmacy or equivalent, since some states license DME suppliers separately from federal Medicare enrollment
• Timeline: three to six months from application submission to active Medicare billing status

United Kingdom

• MHRA device registration - required for manufacturers and importers placing a medical or IVD device on the Great Britain market, across Class I, IIa, IIb and III; the statutory fee is £240 per registration application. GOV.UK, 2026
• Distributors who don't import are generally exempt from direct MHRA registration - but if you import stock yourself from outside the UK, or relabel/refurbish devices under your own name, registration applies to you
• UKCA/CE marking transition - devices marked under the old MDD/AIMDD regime remain acceptable on the GB market until the sooner of certificate expiry or 30 June 2028; MDR/IVDR-marked stock is accepted until 30 June 2030
• Public and product liability insurance - typically £5M+ cover recommended for a retailer handling clinical mobility and respiratory equipment
• VAT relief awareness - many mobility aids and medical supplies qualify for VAT zero-rating when sold to a disabled customer for personal/domestic use; your point-of-sale and invoicing process needs to handle this correctly

Canada

• Medical Device Establishment Licence (MDEL) - required for any importer or distributor of any device class, regardless of volume sold; this applies even to a single-location retailer importing stock directly rather than buying through a Canadian wholesaler
• Timeline: approximately 120 calendar days for Health Canada's standard review
• Ongoing quality system obligations - MDEL holders must maintain procedures for purchasing, storage, distribution, complaint handling, document control and incident/recall reporting aligned with ISO 13485 principles. Health Canada, 2026

Common Mistakes to Avoid

These are the mistakes Avvale sees most often in medical supply founders' first-draft business plans - every one of them is avoidable with the right sequencing in the plan itself.

• Buying inventory before accreditation is finalized. DMEPOS accreditation takes three to six months. Founders who purchase a full inventory load on day one, before accreditation clears, often sit on $50,000-$100,000 of stock generating zero Medicare-billed revenue for a full quarter or more.
• Treating the $50,000 surety bond as a cash outlay rather than an insurance premium. The bond's actual cost is the annual premium - $500 to $1,500 - not the $50,000 face value. Business plans that model the full $50,000 as a startup cost inflate their funding ask and undermine lender confidence.
• Building a payer mix too concentrated in fixed fee-schedule categories. Medicare/Medicaid reimbursement rates are set, not negotiated, and get compressed further in competitive bidding areas. A plan that assumes 70%+ Medicare revenue without stress-testing fee-schedule compression is a red flag to any lender who has seen a DME loan go bad before.
• Operating from a personal residence. CMS requires a qualified physical practice location, open to the public and properly staffed and stocked - a home office does not qualify and will block accreditation outright, regardless of how strong the rest of the application is.
• Running inventory and resupply manually. Spreadsheet-based tracking is the single biggest driver of billing denials and missed resupply orders in year one. Naming a specific system - Brightree or NikoHealth - in the operations section of your plan signals to lenders that the founder has thought past the funding ask to actual day-to-day execution.
• Skipping eligibility verification before dispatch. Sending equipment out before confirming insurance eligibility and prior authorization is the fastest way to turn a sale into an unpaid claim. This single process step, built into the fulfillment workflow from day one, prevents most of the denied-claim write-offs that erode margin in a new operator's first year.
• Underestimating the referral-channel build time. Discharge planners and home health agencies typically take 60-90 days to start sending consistent referral volume to a new supplier, because trust in a new vendor builds slowly in a clinical setting. Plans that assume meaningful referral revenue in month one are almost always wrong, and the shortfall usually has to be covered by cash-pay sales or additional working capital.

See Inside a Medical Supply Business Plan

Preview the structure and financial outputs a buyer receives. These visual mockups are generated from the same assumptions used throughout this page.

What You Get With the Template

Every Avvale business plan template includes these sections, pre-structured for your industry:

• Executive Summary - Your business at a glance, written to hook investors in 60 seconds
• Company Overview - Legal structure, ownership, location, and founding story
• Industry Analysis - Market size, growth trends, and regulatory landscape, including the DMEPOS accreditation pathway
• Customer Analysis - Payer mix modelling (Medicare/Medicaid, cash, private insurance) and referral-source mapping
• Competitor Analysis - Local competitive mapping against national DME players and your differentiation strategy
• Marketing Plan - Referral-channel development, discharge-planner and home-health-agency partnerships
• Operations Plan - Inventory management, resupply automation, delivery workflows, and billing software selection
• Management Team - Founder bios, advisory board, and key hires planned

The optional Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with income statement, cash flow, balance sheet, break-even analysis, and startup capital requirements - modelled with accreditation costs and payer-mix collection timelines separated out, not blended into a single generic cost line.

Because this niche has a genuine compliance dependency that most industries don't - you cannot bill your largest payer category until a third-party accreditation body signs off - Avvale's research process for a bespoke medical supply plan starts by confirming your intended accreditation organization and state licensing requirements before a single financial projection is built. That sequencing avoids the single most common failure mode in this industry: a polished plan built around Medicare revenue assumptions that can't actually go live for another five months.

Frequently Asked Questions

Related Guides

Building a plan for an adjacent healthcare business? These Avvale guides cover related ground:

• Pharmaceutical Distribution Business Plan Template - for founders distributing medicines rather than devices and consumables
• Wholesale Pharmacy Business Plan Template - for pharmacy-side wholesale and dispensing operations
• Free Business Plan Template Library - browse every free industry template Avvale offers
• Work With a Business Plan Writer - talk to a consultant before you commit to a structure